1,042
Views
1
CrossRef citations to date
0
Altmetric
Original Articles: BiGART 2023 Issue

Acute normal tissue responses in a murine model following fractionated irradiation of the head and neck with protons or X-rays

ORCID Icon, , , , , , , , , & show all
Pages 1574-1580 | Received 27 May 2023, Accepted 26 Aug 2023, Published online: 13 Sep 2023

References

  • Barazzuol L, Coppes RP, van Luijk P. Prevention and treatment of radiotherapy-induced side effects. Mol Oncol. 2020;14(7):1538–1554. doi: 10.1002/1878-0261.12750.
  • Chibly AM, Aure MH, Patel VN, et al. Salivary gland function, development, and regeneration. Physiol Rev. 2022;102(3):1495–1552. doi: 10.1152/physrev.00015.2021.
  • Siddiqui F, Movsas B. Management of radiation toxicity in head and neck cancers. Semin Radiat Oncol. 2017;27(4):340–349. doi: 10.1016/j.semradonc.2017.04.008.
  • Tian X, Liu K, Hou Y, et al. The evolution of proton beam therapy: current and future status. Mol Clin Oncol. 2018;8(1):15–21. doi: 10.3892/mco.2017.1499.
  • Fontana AO, Augsburger MA, Grosse N, et al. Differential DNA repair pathway choice in cancer cells after proton- and photon-irradiation. Radiother Oncol. 2015;116(3):374–380. doi: 10.1016/j.radonc.2015.08.014.
  • Lupu-Plesu M, Claren A, Martial S, et al. Effects of proton versus photon irradiation on (lymph)angiogenic, inflammatory, proliferative and anti-tumor immune responses in head and neck squamous cell carcinoma. Oncogenesis. 2017;6(7):e354–e354. doi: 10.1038/oncsis.2017.56.
  • Nielsen S, Bassler N, Grzanka L, et al. Differential gene expression in primary fibroblasts induced by proton and cobalt-60 beam irradiation. Acta Oncol. 2017;56(11):1406–1412. doi: 10.1080/0284186X.2017.1351623.
  • Nielsen S, Bassler N, Grzanka L, et al. Comparison of coding transcriptomes in fibroblasts irradiated with low and high let proton beams and cobalt-60 photons. Int J Radiat Oncol Biol Phys. 2019;103(5):1203–1211. doi: 10.1016/j.ijrobp.2018.11.065.
  • Vitti ET, Parsons JL. The radiobiological effects of proton beam therapy: impact on DNA damage and repair. Cancers (Basel). 2019;11(7):946. doi: 10.3390/cancers11070946.
  • Paganetti H. Mechanisms and review of clinical evidence of variations in relative biological effectiveness in proton therapy. Int J Radiat Oncol Biol Phys. 2022;112(1):222–236. doi: 10.1016/j.ijrobp.2021.08.015.
  • McNamara AL, Schuemann J, Paganetti H. A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data. Phys Med Biol. 2015;60(21):8399–8416. doi: 10.1088/0031-9155/60/21/8399.
  • Paganetti H. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys Med Biol. 2014;59(22):R419–72. doi: 10.1088/0031-9155/59/22/R419.
  • Sorensen BS, Horsman MR, Alsner J, et al. Relative biological effectiveness of carbon ions for tumor control, acute skin damage and late radiation-induced fibrosis in a mouse model. Acta Oncol. 2015;54(9):1623–1630. doi: 10.3109/0284186X.2015.1069890.
  • Sorensen BS, Bassler N, Nielsen S, et al. Relative biological effectiveness (RBE) and distal edge effects of proton radiation on early damage in vivo. Acta Oncol. 2017;56(11):1387–1391. doi: 10.1080/0284186X.2017.1351621.
  • Sorensen BS, Pawelke J, Bauer J, et al. Does the uncertainty in relative biological effectiveness affect patient treatment in proton therapy? Radiother Oncol. 2021;163:177–184. doi: 10.1016/j.radonc.2021.08.016.
  • Saager M, Peschke P, Brons S, et al. Determination of the proton RBE in the rat spinal cord: is there an increase towards the end of the spread-out Bragg peak? Radiother Oncol. 2018;128(1):115–120. doi: 10.1016/j.radonc.2018.03.002.
  • Jones B. Why RBE must be a variable and not a constant in proton therapy. Br J Radiol. 2016;89(1063):20160116. doi: 10.1259/bjr.20160116.
  • Meijer TWH, Scandurra D, Langendijk JA. Reduced radiation-induced toxicity by using proton therapy for the treatment of oropharyngeal cancer. Br J Radiol. 2020;93(1107):20190955. doi: 10.1259/bjr.20190955.
  • Cao J, Zhang X, Jiang B, et al. Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia. Radiother Oncol. 2021;160:32–39. doi: 10.1016/j.radonc.2021.03.036.
  • Blanchard P, Garden AS, Gunn GB, et al. Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis. Radiother Oncol. 2016;120(1):48–55. doi: 10.1016/j.radonc.2016.05.022.
  • Andreo P, Cunningham JR, Hohlfeld K, et al. Absorbed dose determination in photon and electron beams. An international Code of Practice. 1987.
  • Niroomand‐Rad A, Chiu‐Tsao ST, Grams MP, et al. Report of AAPM task group 235 radiochromic film dosimetry: an update to TG‐55. Med Phys. 2020;47(12):5986–6025. doi: 10.1002/mp.14497.
  • Mallick S, Benson R, Rath GK. Radiation induced oral mucositis: a review of current literature on prevention and management. Eur Arch Otorhinolaryngol. 2016;273(9):2285–2293. doi: 10.1007/s00405-015-3694-6.
  • Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004;100(9 Suppl):1995–2025. doi: 10.1002/cncr.20162.
  • Trotti A, Byhardt R, Stetz J, et al. Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47(1):13–47. doi: 10.1016/s0360-3016(99)00559-3.
  • Bagavant H, Trzeciak M, Papinska J, et al. A method for the measurement of salivary gland function in mice. J Vis Exp. 2018;(131):57203. doi: 10.3791/57203.
  • Juvkam IS, Zlygosteva O, Arous D, et al. A preclinical model to investigate normal tissue damage following fractionated radiotherapy to the head and neck. J Radiat Res. 2023;64(1):44–52. doi: 10.1093/jrr/rrac066.
  • Heuchel L, Hahn C, Pawelke J, et al. Clinical use and future requirements of relative biological effectiveness: survey among all european proton therapy centres. Radiother Oncol. 2022; 172:134–139. doi: 10.1016/j.radonc.2022.05.015.
  • Tommasino F, Durante M. Proton radiobiology. Cancers (Basel). 2015;7(1):353–381. doi: 10.3390/cancers7010353.
  • Holliday EB, Kocak-Uzel E, Feng L, et al. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: a case-matched control analysis. Med Dosim. 2016;41(3):189–194. doi: 10.1016/j.meddos.2016.01.002.
  • McDonald MW, Liu Y, Moore MG, et al. Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy. Radiat Oncol. 2016;11(1):32. doi: 10.1186/s13014-016-0600-3.
  • Romesser PB, Cahlon O, Scher E, et al. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation. Radiother Oncol. 2016;118(2):286–292. doi: 10.1016/j.radonc.2015.12.008.
  • Choi C, Lee C, Shin SW, et al. Comparison of proton and photon beam irradiation in Radiation-Induced intestinal injury using a mouse model. Int J Mol Sci. 2019;20(8):1894. doi: 10.3390/ijms20081894.
  • Suarez LJ, Arboleda S, Angelov N, et al. Oral versus gastrointestinal mucosal immune niches in homeostasis and allostasis. Front Immunol. 2021;12:705206. doi: 10.3389/fimmu.2021.705206.
  • Nielsen S, Bassler N, Grzanka L, et al. Proton scanning and X-ray beam irradiation induce distinct regulation of inflammatory cytokines in a preclinical mouse model. Int J Radiat Biol. 2020;96(10):1238–1244. doi: 10.1080/09553002.2020.1807644.
  • Turabelidze A, Guo S, Chung AY, et al. Intrinsic differences between oral and skin keratinocytes. PLoS One. 2014;9(9):e101480. doi: 10.1371/journal.pone.0101480.
  • Waasdorp M, Krom BP, Bikker FJ, et al. The bigger picture: why oral mucosa heals better than skin. Biomolecules. 2021;11(8):1165. doi: 10.3390/biom11081165.